Abstract
Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment: Erratum.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have